glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated versus kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Therapeutic Effects of GLP-1 Receptor
Description
Insulin sensitizers for improving the endocrine and metabolic profile in overweight women with PCOS
doi: 10.1007/s001250050903 [DOI] [PubMed] [Google Scholar] 97
a sulfonylurea)
Vascular biology of glucagon receptor superfamily peptides: mechanistic and clinical relevance
[DOI] [PubMed] [Google Scholar] 24.Ponce M.B., Shields B.E
A massive adoption of GLP-1 drugs in leading markets and growth areas (notably Asian markets) could be a significant blow to many food companies
